Laurence C. Baker

Professor of Health Policy,
Bing Professor of Human Biology,
Senior Fellow, Stanford Institute for Economic Policy Research,
Stanford University;
Associate Chair for Education, Department of Health Policy,
Stanford School of Medicine;
Senior Advisor, Cornerstone Research

For more information, contact:

  • Maria Salgado
  • Anand Krishnamurthy

or any member of our senior staff.


Laurence Baker is an expert in the areas of health economics, healthcare policy, and life sciences. Professor Baker studies the organization and economic performance of U.S. healthcare and pharmaceutical markets, with a focus on issues related to financial incentives, competition, pricing and provider payment, labor, and technology adoption. In the health insurance arena, he has expertise in private insurance, managed care, Medicare Part D, Medicare Advantage, and Medicaid.

Professor Baker has been retained as an expert witness in numerous healthcare and life sciences matters. He has testified in depositions and trials, on issues involving:

  • Healthcare insurance competition
  • Antitrust and intellectual property issues in life sciences matters, including alleged generic entry delay through reverse payments and other allegedly collusive agreements between drug manufacturers
  • Alleged inappropriate use, or inappropriate pricing, of medical services and prescription drugs
  • Mergers between hospitals and physician groups
  • Alleged exclusionary contracting practices by health insurers and health providers
  • Alleged collusive and no-poach labor agreements between health providers
  • Regulatory issues in healthcare

Professor Baker has extensive experience addressing issues of class certification (of both direct and indirect purchasers) as well as evaluating liability and damages.

In his research, Professor Baker has examined the relationship between physician practice characteristics and competition and healthcare delivery, prices, and outcomes. He has also studied the effects of managed care insurance practices on the healthcare system; the impact of regulation on healthcare markets; the determinants and results of technological change in medicine; and patient safety in U.S. hospitals. In addition, Professor Baker has addressed topics related to physicians’ incomes and career choices and analyzed how the internet and email influence healthcare delivery and outcomes.

Professor Baker was awarded the ASHEcon Medal for his significant contributions to the field of health economics and has been elected to the National Academy of Medicine. He has twice been honored for excellence in teaching. His publications include articles in JAMA—The Journal of the American Medical Association, the New England Journal of Medicine, the RAND Journal of Economics, Health Services Research, and Health Affairs.


Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al.


In re Novartis and Par Antitrust Litigation

Press Release

Cornerstone Research Nominated for Global Competition Review Awards 2020


Hospital Pricing Challenged in Class Action


Oscar Insurance Company of Florida v. Blue Cross and Blue Shield of Florida, Inc. et al.


Class Action Related to Changes in Retirees’ Health Insurance Plans


Cornerstone Research and SIEPR Cosponsored Healthcare Conference


Class Certification Opposed on Behalf of Healthcare Provider

  • Seventh Annual Federal Trade Commission Microeconomics Conference, 16 October 2014